REPLAY:
Stop the Shot Conference
Watch!
News

“EMERGENCY CONTRACEPTION” MARKETER MERGES WITH BRITISH CO.

TORONTO, Jan 4 (LifeSiteNews.com) – Roberts Pharmaceutical Corporation, the US company which has begun marketing the abortifacient drug Preven in […]

LifeSite
LifeSite
Comments 

TORONTO, Jan 4 (LifeSiteNews.com) – Roberts Pharmaceutical Corporation, the US company which has begun marketing the abortifacient drug Preven in Canada, completed a merger with the British company Shire Pharmaceuticals Group in December. In anticipation of the expanded boycott LifeSite readers may wish to inform Shire that due to their involvement with Roberts, and thus the promotion and distribution of abortifacient drugs in Canada, they will be boycotted.

Rolf Stahel, Chief Executive
Shire Pharmaceuticals
East Anton, Andover Hampshire, SP10 5RG

Tel: +44 1264 348501
Email: [email protected]

For the boycott announcement against Roberts click here.

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.